Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?
- 28 February 2002
- journal article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 73 (2), 394-402
- https://doi.org/10.1016/s0003-4975(01)03432-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- A threshold method to improve standardized uptake value reproducibilityNuclear Medicine Communications, 2000
- Prognostic Importance of the Standardized Uptake Value on 18F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 CasesJournal of Clinical Oncology, 1999
- PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinomaThe Annals of Thoracic Surgery, 1999
- Pulmonary abnormalities and PET data analysis: a retrospective study.Radiology, 1997
- Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.American Journal of Respiratory and Critical Care Medicine, 1996
- Staging non—small cell lung cancer by whole-body positron emission tomographic imagingThe Annals of Thoracic Surgery, 1995
- CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group.Radiology, 1991